BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
Vaccination with Mycobacterium bovis bacille Calmette-Guérin (BCG) is widely used to reduce the risk of childhood tuberculosis and has been reported to have efficacy against two other mycobacterial diseases, leprosy and Buruli ulcer caused by M. ulcerans (Mu). Studies in experimental models have al...
Saved in:
Main Authors: | Paul J Converse (Author), Deepak V Almeida (Author), Eric L Nuermberger (Author), Jacques H Grosset (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2011-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice.
by: Deepak Almeida, et al.
Published: (2011) -
Rapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infection.
by: Tianyu Zhang, et al.
Published: (2013) -
Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.
by: Paul J Converse, et al.
Published: (2014) -
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.
by: Deepak V Almeida, et al.
Published: (2013) -
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
by: Fred Stephen Sarfo, et al.
Published: (2013)